SCHEMBL5164953

SCHEMBL5164953

CCCc1ccc(O)c(CC(C)C)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.73
GABRB2 P47870 3/20 0.73
CNR1 P21554 2/20 0.56
CNR2 P34972 1/20 0.56
ALOX5 P09917 3/20 0.53
BACE1 P56817 1/20 0.50
ALOX15 P16050 3/20 0.43
ALOX12 P18054 3/20 0.43
CYP3A4 P08684 3/20 0.43
HIF1A Q16665 3/20 0.43
HSD17B10 Q99714 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
ESR1 P03372 2/20 0.43
TP53 P04637 2/20 0.43
HPGD P15428 2/20 0.43
MAPK1 P28482 2/20 0.43
RECQL P46063 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164394 0.90 GABRA1 (0.69) GABRA1GABRB2CNR1CNR2ALOX5
SCHEMBL13293274 0.86 GABRA1 (0.73) GABRA1GABRB2CNR1ALOX5BACE1
SCHEMBL5168024 0.86 GABRA1 (0.73) GABRA1GABRB2CNR1CNR2ALOX5
SCHEMBL5165465 0.86 GABRA1 (0.53) GABRA1GABRB2CNR1CNR2ALOX5
SCHEMBL5167205 0.85 GABRA1 (0.79) GABRA1GABRB2CNR1ALOX5BACE1
SCHEMBL318750 0.85 GABRA1 (1.00) GABRA1GABRB2CNR1ALOX5BACE1
SCHEMBL7922257 0.83 GABRA1 (0.81) GABRA1GABRB2CNR1ALOX5BACE1
SCHEMBL1021086 0.83 ALOX5 (0.71) GABRA1GABRB2CNR1CNR2ALOX5
SCHEMBL28876297 0.81 CNR1 (0.60) GABRA1GABRB2CNR1CNR2ALOX5
SCHEMBL1022604 0.81 BACE1 (0.72) GABRA1GABRB2CNR1CNR2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-210381446-U Printed wiring board with electromagnetic wave shielding sheet 东洋油墨SC控股株式会社 2020-04-21 CN disclosed
CN-110784998-A Printed wiring board with electromagnetic wave shielding sheet 东洋油墨SC控股株式会社 2020-02-11 CN disclosed
WO-2020021717-A1 DRY RESIST FILM, SOLDER RESIST, PRINTED WIRING BOARD WITH ELECTROMAGNETIC WAVE SHIELD SHEET AND METHOD FOR MANUFACTURING SAME, AND ELECTRONIC DEVICE 東洋インキSCホールディングス株式会社 2020-01-30 WO disclosed
CN-102854744-A Photosensitive resin composition, cured product thereof, and method for producing photosensitive resin TOYO INK SC HOLDINGS CO LTD 2013-01-02 CN disclosed
US-20110046160-A1 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases PFIZER, INC. 2011-02-24 US disclosed
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls BASF AKTIENGESELLSCHAFT (DE) 2007-06-07 US disclosed
EP-1633691-B1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AG (DE) 2007-04-11 EP disclosed
CN-1946769-A Sulfur-containing compound, process for producing the same, sulfur-containing polymer, and optical material IDEMITSU KOSAN CO (JP) 2007-04-11 CN disclosed
EP-1682473-A1 METHOD FOR THE PRODUCTION OF 2,2'-DIHYDROXYBIPHENYLS BASF Aktiengesellschaft (DE) 2006-07-26 EP disclosed
CN-1802339-A Method for producing 2,2'-dihydroxy-biphenyls BASF AG (DE) 2006-07-12 CN disclosed
EP-1633691-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2006-03-15 EP disclosed
WO-2005042454-A1 METHOD FOR THE PRODUCTION OF 2,2'-DIHYDROXYBIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2005-05-12 WO disclosed
WO-2004108642-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2004-12-16 WO disclosed
WO-2004069779-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXYBIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls HAO2, DAO, DDO GABRA1 1782/4885GABRB2 1341/4885CNR1 2059/4885
US-20110046160-A1 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases SNCA, PARK7, HTT GABRA1 1390/4885GABRB2 1478/4885CNR1 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.